Stock Comparison

NBIX vs TEVA

Neurocrine Biosciences Inc and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.

NBIX

Neurocrine Biosciences Inc

Healthcare

TEVA

Teva Pharma Industries Ltd ADR

Healthcare

Valuation

Market Cap

$15.19B

$41.60B

P/E (TTM)

21.8

59.5

Forward P/E

22.1

17.2

Price/Sales

4.5

2.4

Price/Book

4.1

5.4

EV/EBITDA

16.5

20.9

Dividend Yield

—

Profitability

Net Margin

21.55%

9.02%

Operating Margin

25.19%

13.19%

Return on Equity

22.10%

9.69%

Return on Assets

11.70%

5.13%

Growth (YoY)

Revenue Growth

39.50%

-0.80%

Earnings Growth

31.10%

72.20%

Price & Risk

Beta

0.4

0.9

52-Week High

$185.50

$36.74

52-Week Low

$123.10

$17.54

Analyst Target

$213.13

$41.20

Compare NBIX and TEVA your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.